Shionogi & Co., Ltd. (TYO:4507)
3,536.00
+1.00 (0.03%)
Feb 13, 2026, 3:30 PM JST
Shionogi & Revenue
Shionogi & had revenue of 147.72B JPY in the quarter ending December 31, 2025, with 23.48% growth. This brings the company's revenue in the last twelve months to 465.38B, up 1.86% year-over-year. In the fiscal year ending March 31, 2025, Shionogi & had annual revenue of 438.27B with 0.73% growth.
Revenue (ttm)
465.38B
Revenue Growth
+1.86%
P/S Ratio
6.46
Revenue / Employee
93.92M
Employees
4,955
Market Cap
3.01T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 438.27B | 3.19B | 0.73% |
| Mar 31, 2024 | 435.08B | 8.40B | 1.97% |
| Mar 31, 2023 | 426.68B | 91.55B | 27.32% |
| Mar 31, 2022 | 335.14B | 37.96B | 12.77% |
| Mar 31, 2021 | 297.18B | -36.19B | -10.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Toho Holdings | 1.53T |
| Eisai | 808.19B |
| Sumitomo Pharma | 453.40B |
| Towa Pharmaceutical | 266.67B |
| Sawai Group Holdings | 200.00B |
| Tsumura & Co. | 189.50B |
| Nippon Shinyaku | 166.05B |
Shionogi & News
- 10 days ago - Shionogi & Co. GAAP EPS of ¥188.00, revenue of ¥500B - Seeking Alpha
- 23 days ago - Pfizer (PFE) to Exit ViiV Healthcare Stake as Shionogi Increases Investment - GuruFocus
- 23 days ago - Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake - Seeking Alpha
- 23 days ago - GSK and Shionogi Restructure Stake in ViiV Healthcare - GuruFocus
- 23 days ago - Shionogi Increases Stake in ViiV Healthcare with $2.13 Billion Investment - GuruFocus
- 23 days ago - Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits - Reuters
- 7 months ago - Shionogi & Co., Ltd. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript - Seeking Alpha